آزمون بایوبردن

Bioburden Testing of Medical Devices

What Is Bioburden

Bioburden refers to the total number of viable microorganisms, including bacteria, yeasts, and molds, present on the surface or within a non-sterile product prior to sterilization. This microbial contamination may originate from raw materials, manufacturing processes, human handling, cleanroom environments, or packaging and transportation activities.

Bioburden testing is one of the most critical microbiological tests in the medical device and pharmaceutical industries and is performed to quantify this microbial load. The results provide the scientific and technical basis for designing, selecting, and validating sterilization processes and play a direct role in ensuring patient safety. Bioburden results are reported as colony forming units (CFU) per unit of product, such as CFU/device, CFU/mL, CFU/g, or CFU/cm².

Why Is Bioburden Testing Critically Important

The importance of bioburden testing extends beyond simple microbial enumeration. This test:

Provides the scientific basis for defining sterilization parameters
Plays a key role in achieving a Sterility Assurance Level (SAL = 10⁻⁶)
Serves as a primary tool for microbiological quality control in manufacturing
Is required for regulatory approvals and CE marking
Is directly reviewed during ISO 13485, GMP, and ISO 17025 audits

Without reliable bioburden data, no sterilization process can be scientifically or regulatorily justified.

Objectives of Bioburden Testing

Bioburden testing is conducted to:

Determine the true level of microbial contamination prior to sterilization
Evaluate the effectiveness of cleaning, washing, and disinfection processes
Monitor microbial contamination throughout manufacturing stages
Identify critical contamination points within the production line
Provide input data for sterilization validation using EO, gamma radiation, or steam
Reduce the risk of post-sterilization contamination

Reference Standards for Bioburden Testing

Bioburden testing is performed in accordance with internationally recognized standards, including:

ISO 11737-1: Determination of microbial population on medical devices prior to sterilization
“USP and EP 2.6.12: Microbial Enumeration Tests”

Direct linkage to sterilization standards such as:

ISO 11135 (Ethylene Oxide)
ISO 11137 (Radiation Sterilization)

Bioburden testing must be fully compliant with these standards and traceable.

Microbiological Indicators in Bioburden Testing

In bioburden testing, two primary indicators are typically evaluated

TAMC – Total Aerobic Microbial Count

This indicator represents the total number of aerobic mesophilic bacteria, which is measured using Tryptic Soy Agar (TSA) culture medium.

TYMC – Total Yeast and Mold Count

This indicator represents the number of yeasts and molds and is typically measured using Sabouraud Dextrose Agar (SDA) culture medium. Sabouraud Dextrose Agar (SDA) اندازه‌گیری می‌شود.

Where required, additional tests such as anaerobic counts or identification of predominant microorganisms may be performed.

Bioburden Test Methods

Membrane Filtration Method:

One of the most accurate and widely used methods, particularly for liquid products or extractable samples. Microorganisms are captured on membranes with pore sizes ≤0.45 µm, then cultured and enumerated.

Direct Plating Method (Plate Count):

Used for solid or non-filterable products and includes Spread Plate and Pour Plate techniques.

Factors Affecting Bioburden Levels

Bioburden levels may be influenced by:

Quality of raw materials and suppliers
Personnel hygiene practices
Equipment cleaning and maintenance status
Cleanroom classification and environmental conditions
Packaging, storage, and transportation processes

Controlling these factors is essential to reduce bioburden and ensure sterilization process stability.

Role of Bioburden Testing in Quality Control

Bioburden testing enables manufacturers to:

Assess manufacturing process consistency
Detect unwanted changes in contamination levels
Implement effective corrective and preventive actions (CAPA)
Minimize patient safety risks

Final Summary

بایوبردن Bioburden is a critical indicator for assessing the microbiological status of medical devices prior to sterilization. Accurate and standard-compliant bioburden testing is not only a regulatory requirement but also an integral part of a professional, reliable, and patient-safety–focused quality management system.